These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 1834827)
1. Pharmacokinetics and bioavailability of a new formulation of teicoplanin following intravenous and intramuscular administration to humans. Antony KK; Lewis EW; Kenny MT; Dulworth JK; Brackman MB; Kuzma R; Yuh L; Eller MG; Thompson GA J Pharm Sci; 1991 Jun; 80(6):605-7. PubMed ID: 1834827 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of teicoplanin upon multiple-dose intravenous administration of 3, 12, and 30 milligrams per kilogram of body weight to healthy male volunteers. Smithers JA; Kulmala HK; Thompson GA; Antony KK; Lewis EW; Ruberg SJ; Kenny MT; Dulworth JK; Brackman MA Antimicrob Agents Chemother; 1992 Jan; 36(1):115-20. PubMed ID: 1534211 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of teicoplanin upon multiple dose intravenous administration to normal healthy male volunteers. Thompson GA; Smithers JA; Kenny MT; Dulworth JK; Kulmala HK; Yuh L; Lewis EW; Antony KK Biopharm Drug Dispos; 1992 Apr; 13(3):213-20. PubMed ID: 1533542 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of 14C-teicoplanin in healthy volunteers. Buniva G; Del Favero A; Bernareggi A; Patoia L; Palumbo R J Antimicrob Chemother; 1988 Jan; 21 Suppl A():23-8. PubMed ID: 2965128 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of a single intravenous dose of teicoplanin in subjects with various degrees of renal impairment. Bonati M; Traina GL; Rosina R; Buniva G J Antimicrob Chemother; 1988 Jan; 21 Suppl A():29-37. PubMed ID: 2965129 [TBL] [Abstract][Full Text] [Related]
13. In vitro activity and human pharmacokinetics of teicoplanin. Verbist L; Tjandramaga B; Hendrickx B; Van Hecken A; Van Melle P; Verbesselt R; Verhaegen J; De Schepper PJ Antimicrob Agents Chemother; 1984 Dec; 26(6):881-6. PubMed ID: 6240962 [TBL] [Abstract][Full Text] [Related]
14. Safety, Tolerability, and Pharmacokinetic Properties of Intravenous Delafloxacin After Single and Multiple Doses in Healthy Volunteers. Hoover R; Hunt T; Benedict M; Paulson SK; Lawrence L; Cammarata S; Sun E Clin Ther; 2016 Jan; 38(1):53-65. PubMed ID: 26718605 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of individual components of teicoplanin in man. Bernareggi A; Danese A; Cometti A; Buniva G; Rowland M J Pharmacokinet Biopharm; 1990 Dec; 18(6):525-43. PubMed ID: 2149149 [TBL] [Abstract][Full Text] [Related]
16. Bioavailability and pharmacokinetic profile of levofloxacin following intravenous, intramuscular and oral administration in turkeys. Aboubakr M; Uney K; Elmas M Br Poult Sci; 2014 Feb; 55(1):115-9. PubMed ID: 24735473 [TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of teicoplanin in varying degrees of renal function. Lam YW; Kapusnik-Uner JE; Sachdeva M; Hackbarth C; Gambertoglio JG; Sande MA Clin Pharmacol Ther; 1990 May; 47(5):655-61. PubMed ID: 2140543 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of teicoplanin in subjects with varying degrees of renal function. Derbyshire N; Webb DB; Roberts D; Glew D; Williams JD J Antimicrob Chemother; 1989 Jun; 23(6):869-76. PubMed ID: 2527223 [TBL] [Abstract][Full Text] [Related]
19. Teicoplanin pharmacokinetics in healthy volunteers after administration of intravenous loading and maintenance doses. Outman WR; Nightingale CH; Sweeney KR; Quintiliani R Antimicrob Agents Chemother; 1990 Nov; 34(11):2114-7. PubMed ID: 2149920 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of sequential intravenous and subcutaneous teicoplanin in critically ill patients without vasopressors. Barbot A; Venisse N; Rayeh F; Bouquet S; Debaene B; Mimoz O Intensive Care Med; 2003 Sep; 29(9):1528-34. PubMed ID: 12856119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]